Ironclad Steel Products (ICSP) — Senior Unsecured Notes 7.50%
Executive Summary
Demo purchase of $100M face of Senior Unsecured Notes 7.50% at 97.0 (cash investment $97.5M): current yield 7.7%, yield to maturity 8.6%. Recommendation: HOLD. Credit score 93/100 (Low risk). Base-case IRR 8.5%, downside 5.3%, severe -3.7%; probability-weighted IRR 5.4% vs a 12% hurdle; weighted P(default) 15%; severe-case valuation recovery 52%. HOLD (do not size yet): Base-case IRR clears hurdle (8.5% vs ≥ 12.0%); Expected-cash-flow IRR (probability-weighted) clears hurdle (5.4% vs ≥ 12.0%); Entry yield meets minimum (8.6% vs ≥ 9.0%).
Investment Thesis
Low leverage today, but steel is the most cyclical name on our list. Unsecured notes at 97 pay a fair coupon; we want to see what the severe case does to secured-vs-unsecured recovery before sizing.
The question: Does a 8.6% yield on a rank-3 unsecured claim compensate for 15% probability-weighted default risk and 48% severe-case loss?
Company Overview
Mini-mill producer of specialty bar and plate steel with cyclical end markets. HQ Pittsburgh, PA; Materials / Specialty Steel. FY2025A revenue $3.2B, EBITDA $384M (12.0% margin); total debt $1.0B, cash $210M. DEMO DATA
Industry / Market
Steel margins swing with spreads over scrap and demand cycles; leverage through the trough matters more than point-in-time metrics.
Historical Financial Performance
| $M | FY2022A | FY2023A | FY2024A | FY2025A |
|---|---|---|---|---|
| Revenue | $3.3B | $3.5B | $3.4B | $3.2B |
| % growth | 7.7% | -4.3% | -4.5% | |
| Direct costs / COGS | $2.5B | $2.8B | $2.7B | $2.6B |
| Gross profit (NOI for real estate) | $715.0M | $735.0M | $686.8M | $640.0M |
| % margin | 22.0% | 21.0% | 20.5% | 20.0% |
| Operating expenses (cash, adjusted) | $260.0M | $280.0M | $268.0M | $256.0M |
| EBITDA (company-adjusted basis) | $455.0M | $455.0M | $418.8M | $384.0M |
| % margin | 14.0% | 13.0% | 12.5% | 12.0% |
| D&A | $130.0M | $140.0M | $134.0M | $128.0M |
| Share-based compensation | $0.0M | $0.0M | $0.0M | $0.0M |
| EBIT | $325.0M | $315.0M | $284.8M | $256.0M |
| Interest expense | $60.7M | $64.3M | $67.8M | $71.4M |
| EBT | $264.3M | $250.7M | $216.9M | $184.6M |
| Taxes | $66.1M | $62.7M | $54.2M | $46.1M |
| Net income (model basis) | $198.2M | $188.1M | $162.7M | $138.4M |
| Capex | $162.5M | $175.0M | $167.5M | $160.0M |
| Working capital & other cash items | $9.6M | $37.5M | ($22.5M) | ($22.5M) |
| Free cash flow | $156.2M | $115.6M | $151.7M | $128.9M |
Capital Structure
| Tranche | Rank | Secured | Face value | Rate | Maturity | Mark / price |
|---|---|---|---|---|---|---|
| ABL Revolver | 1 | Yes | $0.0M | S+225bp | 2029-04-30 | — |
| Senior Secured Notes 6.90% | 1 | Yes | $600.0M | 6.90% | 2030-04-15 | 100.5 |
| Senior Unsecured Notes 7.50% | 3 | No | $400.0M | 7.50% | 2029-08-15 | 97.0 |
Total debt $1.0B (2.6x EBITDA); net debt $790.0M; liquidity $610M; loan-to-value through the target tranche 58%.
Credit Analysis
Net leverage 2.1x, EBITDA / interest 5.38x, FCF / debt 12.9%, DSCR 2.5x, liquidity ratio 8.5x. Score components: Leverage 15/15, Coverage 15/15, Liquidity 10/10, Free cash flow 10/10, Maturity risk 10/10, Margin stability 10/10, Revenue stability 6/8, Asset coverage 12/12, Industry risk 5/10. Score change vs FY2024A (same capital structure): 93 → 93 (no material factor change).
Debt Maturity Profile
| Period | Debt due | % of debt | Projected liquidity (Base) | Refinancing requirement |
|---|---|---|---|---|
| FY2029E | $400M | 40% | $1.1B | — |
| FY2030E | $600M | 60% | $816M | — |
| Tranche | Matures | Balance at maturity | Cash on hand | Net lev. (test ≤) | Pro-forma coverage (test ≥) | Refi rate | Interest burden after | Result | Resolution |
|---|---|---|---|---|---|---|---|---|---|
| ABL Revolver | FY2029E | $0.0M | $535M | 1.1x (8.5x) | 6.11x (1.20x) | 7.5% | $0.0M | REFINANCING PASS | Repaid from cash |
| Senior Unsecured Notes 7.50% | FY2029E | $400.0M | $535M | 1.1x (8.5x) | 6.11x (1.20x) | 7.5% | $0.0M | REFINANCING PASS | Repaid from cash |
| Senior Secured Notes 6.90% | FY2030E | $600.0M | $260M | 0.8x (8.5x) | 10.05x (1.20x) | 7.5% | $13.8M | REFINANCING PASS | Partly repaid from cash; remainder refinanced |
Base Case
Revenue CAGR 2.0%; FY2030E EBITDA $452M (12.8% margin); trough EBITDA $392M; peak net leverage 1.8x; minimum EBITDA / interest 5.49x; cumulative FCF $606M. No payment default modelled. IRR 8.5%, MOIC 1.26x.
Downside Case
Revenue CAGR -1.6%; FY2030E EBITDA $277M (9.4% margin); trough EBITDA $209M; peak net leverage 3.4x; minimum EBITDA / interest 2.93x; cumulative FCF $135M. No payment default modelled. IRR 5.3%, MOIC 1.15x.
Severe Downside
Revenue CAGR -8.4%; FY2030E EBITDA $113M (5.5% margin); trough EBITDA $33M; peak net leverage 25.3x; minimum EBITDA / interest 0.46x; cumulative FCF ($281M). Payment default modelled in FY2029E; target-tranche recovery 52%. IRR -3.7%, MOIC 0.85x.
Covenant Analysis
No active covenants.
No active covenants.
Recovery Analysis
If the company defaults, recovery value is $858M (liquidation) in the severe case → 52% recovery (48% LGD) on the target tranche; downside 100%. Recovery value = MAX(going concern $382M, liquidation $858M) + cash, less administrative costs; severe case struck at FY2029E.
| Claim (by seniority) | Rank | Claim | Recovery | Recovery % | Loss | Loss % |
|---|---|---|---|---|---|---|
| Recovery value | $858.0M | |||||
| Less: administrative / DIP costs | ($34.3M) | |||||
| Senior Secured Notes 6.90% | 1 | $610.4M | $610.4M | 100.0% | $0.0M | 0.0% |
| Senior Unsecured Notes 7.50% | 3 | $407.5M | $213.3M | 52.4% | $194.2M | 47.6% |
| Total claims | $1.0B | $823.7M | $194.2M | |||
| Equity (residual) | $0.0M | Wiped out | ||||
Investment Returns
| Base Case | Downside | Severe Downside | |
|---|---|---|---|
| Face value / purchase price / cash investment | $100M / 97.0 / $97.5M UNDERWRITING ASSUMPTION | ||
| Cash interest + exit/recovery proceeds | $22.5M + $100.0M | $22.5M + $90.0M | $30.0M + $53.3M |
| Capital gain / (loss) vs purchase price | $3.0M | ($7.0M) | ($43.7M) |
| MOIC | 1.26x | 1.15x | 0.85x |
| IRR (hurdle 12%) | 8.5% | 5.3% | -3.7% |
Key Risks
- Severe-case valuation recovery of 52% is below the 97.0 purchase price: a 48% loss given default.
- Severe case produces a payment default in FY2029E.
- Unsecured, rank 3: $600M of debt ranks ahead.
- Weakest credit-score factor: Industry risk (4.5 of 10 points).
- Price/volume cyclicality
Key Protections
- Coverage of 5.38x EBITDA / interest; EBITDA can fall 81% before coverage reaches 1.0x.
- Moderate leverage: net debt / EBITDA 2.1x.
- Liquidity of $610M (61% of total debt).
- Base-case refinancing tests pass for all 3 maturing tranche(s); 2 are repaid from cash.
- No covenant breach in the Downside case.
Catalysts
- Section 232 tariff developments
- Mill outage schedule
Due Diligence Items
| Item | Status | Priority | Open question |
|---|---|---|---|
| Historical financials tied to filings | In Progress | High | Do model inputs reconcile to audited statements? |
| Quality of earnings / EBITDA add-backs | In Progress | High | How much of adjusted EBITDA is add-backs? |
| Free cash flow conversion | In Progress | High | What is cash conversion after capex and working capital? |
| Competitive position and management | Issue Identified | Medium | Share trend and management track record? |
| Debt documentation review | Not Started | High | Priming / drop-down protections and baskets? |
| Covenant package and definitions | Not Started | High | Covenant EBITDA definition and headroom? |
| Maturity profile and refinancing plan | Not Started | High | Is the refinancing plan credible at current leverage? |
| Collateral and lien perfection | In Progress | Medium | What assets secure the instrument? |
| Litigation and contingent liabilities | In Progress | Medium | Any material claims ahead of creditors? |
| Macro and rate sensitivity | Issue Identified | Low | How does the credit behave at +300 bps? |
Recommendation
HOLD. HOLD (do not size yet): Base-case IRR clears hurdle (8.5% vs ≥ 12.0%); Expected-cash-flow IRR (probability-weighted) clears hurdle (5.4% vs ≥ 12.0%); Entry yield meets minimum (8.6% vs ≥ 9.0%).
| Test | Actual | Required | Weight | |
|---|---|---|---|---|
| ✗ | Base-case IRR clears hurdle | 8.5% | ≥ 12.0% | core |
| ✗ | Expected-cash-flow IRR (probability-weighted) clears hurdle | 5.4% | ≥ 12.0% | core |
| ✓ | Downside IRR stays above floor | 5.3% | ≥ 0.0% | core |
| ✓ | Downside recovery meets minimum (valuation waterfall) | 100.0% | ≥ 60.0% | core |
| ✓ | Base-case refinancing succeeds | PASS | PASS | core |
| ✗ | Entry yield meets minimum | 8.6% | ≥ 9.0% | secondary |
| ✓ | Net leverage within maximum | 2.1x | ≤ 6.0x | secondary |
| ✓ | Covenant headroom (base case, minimum) | n/m | ≥ 15.0% | secondary |
| ✗ | Principal protected in severe case (recovery ≥ price) | 52 vs 97.0 | recovery ≥ price | secondary |
| ✗ | No unresolved high-priority diligence | 6 open | 0 open | secondary |
What would change my mind?
- EBITDA declines more than 81% from FY2025A (coverage < 1.0x) — or more than n/m (first covenant breaks).
- The entry price is above 88.7: the base case no longer earns the 12% hurdle (assumed price 97.0).
- Severe-case recovery returns the purchase price only if the distressed valuation multiple is at least 12.3x EBITDA (the severe case assumes 4.5x); the question is how much cushion we want.
- Collateral / enterprise value falls more than 40% from the base-case valuation: the tranche starts to take losses.
- Market access weakens: base-case pro-forma coverage at refinancing is 6.11x vs the 1.20x test, at an assumed 7.5% refinancing rate — a higher spread or lower EBITDA flips the test.
Sources (3)
| Source | Document | Data type | Period | Accession | Doc date | Retrieved | Class |
|---|---|---|---|---|---|---|---|
| CreditIQ demo dataset | Ironclad Steel Products — illustrative financial statements FY2022–FY2025 | Income statement / cash flow | FY2022–FY2025 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Ironclad Steel Products — illustrative capital structure & covenants | Debt schedule | As of 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Illustrative indicative bid marks (% of par) | Market price | 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
Generated entirely from the structured model (inputs → analysis → memo): every figure reconciles to the Excel workbook (see Settings → Reconciliation). Hypothetical terms are underwriting assumptions. Not investment advice.